Chemical Structure (Atorvastatin Calcium Tablets 1)
Atorvastatin Calcium
Product Images NDC 53002-1439
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-1439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Atorvastatin Calcium Tablets 2)
The available text appears to show a graph with the Cumulative incidence expressed as a percentage, accompanied by a Hazard Ratio of 0.64 with a confidence interval of 0.50-0.83 and a p-value of 0.0005. The graph appears to span 404 years with the incidence at 30% at 20 years, 15% at 25 years, and an unknown percentage at 35 years.*
Figure 2 (Atorvastatin Calcium Tablets 3)
The text represents a graph or a chart with the title "Time to First Primary Endpoint Through Four (4) Years of Follow-up (Years)" and two lines plotted as a Cumulative Hazard %. At different time intervals, the first line shows 157%, the second line is at 107%. Below the graph, there is a statistical result that shows HR 0.63 with 95% CI between 0.48 to 0.83 along with the p-value of 0.001.*
Figure 3 (Atorvastatin Calcium Tablets 4)
The text is presenting results of a study that evaluated subjects under treatment with different doses of Atorvastatin. The percentage of subjects experiencing events is not available in this excerpt. The study found that Atorvastatin 80mg had a beneficial effect when compared to Atorvastatin 10mg regarding major cardiovascular endpoints, showing a hazard ratio of 0.78 (with a confidence interval of 0.69-0.89) and P value of 0.0002. The graph shows the time to the first major cardiovascular endpoint in years.*
Label Image (Lbl530021335)
Label Image (Lbl530021439)
Label Image (Lbl530021440)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
